ACT vs CE · P/E 9.3, rev $1.20B vs rev $10.28B
Enact Holdings Inc (ACT) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Enact Holdings Inc (ACT) is a insurance - specialty company listed on NASDAQ.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported ACT revenue for 2024-12-31 was $1.20B. Revenue was up 4.2% from 2023-12-31 to 2024-12-31. ACT currently screens at market cap $5.99B and trailing P/E 9.3.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
ACT currently screens at market cap $5.99B and trailing P/E 9.3. CE currently screens at market cap $5.92B.
Not investment advice. Open the ACT and CE stock pages for the full models.
Not investment advice.